Latest News
Oct 12, 2018

Mylan N.V. (NASDAQ: MYL) today announced that the United States Court of Appeals for the Federal Circuit has affirmed the District of Delaware's decision that Teva's Copaxone® 40 mg/mL dosing...

Oct 12, 2018

Mylan N.V. (NASDAQ: MYL) today announced the launch of Vivarin™ Caffeine Gum to provide adults (18 and older) a convenient way to get an appropriate boost of caffeine with a burst of mint flavor...

Oct 11, 2018

Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma") and Mylan N.V. (NASDAQ: MYL) ("Mylan") today announced that positive new data from multiple studies of YUPELRI™ (revefenacin)...

Oct 8, 2018

Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma") and Mylan N.V. (NASDAQ: MYL) ("Mylan") today announced that data from studies of YUPELRI™ (revefenacin) will be presented at...

Sep 24, 2018

Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) and medical device company Atomo Diagnostics today announced a strategic partnership to commercialize CE-Marked in vitro HIV rapid diagnostic...

View More


Search News Releases

Contact Mylan Communications

Global Communications 
724.514.1968
communications@mylan.com

Stay Connected